Ofatumumab, a Novel CD20 Monoclonal Antibody, Is Active in Patients With Fludarabine- and Alemtuzumab-Refractory or Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia Irrespective of Prior Rituximab

✍ Scribed by Wierda, William; Kipps, Thomas; Mayer, Jiří; Stilgenbauer, Stephan; Williams, Cathy D.; Hellmann, Andrzej; Robak, Tadeusz; Furman, Richard R.; Hillmen, Peter; Trneny, Marek; Dyer, Martin J.S.; Padmanabhan, Swami; Piotrowska, Magdalena; Kozak, Tomas; Chan, Geoffrey; Davis, Randy; Losic, Nedjad; Wilms, Joris; Russell, Charlotte; Österborg, Anders

• Book ID: 119936161
• Publisher: CIG Media Group, LP.
• Year: 2009
• Tongue: English
• Weight: 53 KB
• Volume: 9
• Category: Article
• ISSN: 1557-9190
• DOI: 10.3816/clm.2009.n.098